Latest Strategy News

IPH Limited has updated its dividend announcement, confirming a fully franked ordinary dividend of AUD 0.195 per share and setting the Dividend Reinvestment Plan price at AUD 4.21 per share.

EV Resources has made significant strides at its Los Lirios Antimony Project in Mexico, completing key infrastructure and identifying multiple high-grade drill targets as it moves closer to resource definition.

Assetora Limited has locked in a $3 million private placement from CloudTech Group, aiming to strengthen its balance sheet and fuel expansion plans. The deal unfolds in two tranches, with key conditions tied to audited reports and ASX reinstatement.

Aguia Resources has updated its economic study for the Tres Estrades Rock Phosphate Project, reflecting a significant uplift in phosphate pricing and expanded production capacity that together enhance the project's financial outlook.

Mount Ridley Mines has completed its recent entitlement offer, raising $190,910 but leaving a significant shortfall of shares unsubscribed. The company now faces decisions on how to manage the remaining 202 million shares.

Peninsula Energy has successfully produced its first batch of dried yellowcake uranium at the Lance Project in Wyoming, marking a major step toward becoming a fully independent uranium producer in the US.

Brightstar Resources reports underground mining operations at its Laverton Hub are significantly ahead of schedule, targeting a +50% quarter-on-quarter production increase in the September quarter. The Fish Mine has turned cash flow positive, underpinning a robust growth outlook.

Investigator Resources has agreed to sell its 25% stake in the Molyhil tungsten-molybdenum project to Tivan Limited, unlocking over A$3 million in value and sharpening its focus on precious metals development.

Medallion Metals has taken a crucial step forward by ordering a secondary ball mill to upgrade the Cosmic Boy Concentrator, underpinning its Sulphide Production Strategy and advancing its feasibility study toward a final investment decision.

Race Oncology has uncovered that its anticancer drug bisantrene exists as three light-sensitive isomers, with only one showing potent activity. The company has filed patents to protect this active form, potentially extending its intellectual property rights until 2045.

Paladin Energy has launched a fully underwritten A$300 million equity raising to advance its Patterson Lake South uranium project, aiming for a Final Investment Decision and first production by 2031.

Core Energy Minerals has confirmed uranium mineralisation at its Cummins Project in South Australia through a maiden aircore drilling program, reinforcing its geological model and setting the stage for targeted follow-up exploration.